MedDataX Logo

The Effect of COVID-19 Patients' Serum Phosphate Level on Mortality in ICU

NCT ID: NCT04800770

Last Updated: 2021-03-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

160 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-03-03

Study Completion Date

2021-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators aimed to investigate the relationship between phosphate level and mortality using the 4C Mortality Score in COVID-19 patients who were followed up in the intensive care unit.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Factors Affecting Mortality in Critical Patients Admitted to Intensive Care Unit Due to Coronavirus Disease 2019

NCT04659876

Covid19 and Mortality
COMPLETED

Fluid Balance and Body Weight Changes in Critically Ill Adult Patients

NCT04434079

Critical Illness Fluid Overload
COMPLETED

Hypophosphatemia as a Predictive Marker of Mortality During Sepsis in ICU

NCT03529058

Hypophosphatemia Infection
COMPLETED

Effect of Favipiravir on Mortality in Patients With COVID-19 at a Tertiary Center Intensive Care Unit

NCT04645433

Mortality Intensive Care Unit
COMPLETED

Clinical Characteristics of Critically Ill Patients With COVID-19

NCT04413435

Coronavirus Infection Critical Illness Characteristics Disease
COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Phosphate Deficiency Covid19 Mortality

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

4C mortality score

4C mortality score and phosphate levels

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants hospitalized in the intensive care unit diagnosed with COVID-19 will incluse in the study
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ankara City Hospital Bilkent

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

ismail aytaç

medical doctor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

betül aytaç, MD

Role: PRINCIPAL_INVESTIGATOR

ankara ch bilkent

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ankara City Hospital

Ankara, , Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

betül aytaç, MD

Role: CONTACT

[email protected]
+905073578351

ismail aytaç, MD

Role: CONTACT

[email protected]
+905056340369

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

İsmail Aytac

Role: primary

[email protected]
+905056340369

References

Explore related publications, articles, or registry entries linked to this study.

Murer H, Forster I, Biber J. The sodium phosphate cotransporter family SLC34. Pflugers Arch. 2004 Feb;447(5):763-7. doi: 10.1007/s00424-003-1072-5. Epub 2003 May 16.

Reference Type RESULT
PMID: 12750889 (View on PubMed)

Pistolesi V, Zeppilli L, Polistena F, Sacco MI, Pierucci A, Tritapepe L, Regolisti G, Fiaccadori E, Morabito S. Preventing Continuous Renal Replacement Therapy-Induced Hypophosphatemia: An Extended Clinical Experience with a Phosphate-Containing Solution in the Setting of Regional Citrate Anticoagulation. Blood Purif. 2017;44(1):8-15. doi: 10.1159/000453443. Epub 2017 Feb 21.

Reference Type RESULT
PMID: 28219057 (View on PubMed)

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.

Reference Type RESULT
PMID: 32031570 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

E1-21-1584

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Lactate Clearance in Hospital-acquired Pneumonia
NCT04826848 COMPLETED
CoV-ICU Score, Intensive Care Unit, SARS-CoV-2
NCT04383483 UNKNOWN
Investigation of the Relationship Between Nutritional Status Assessment and Frailty in Critical Care Patients
NCT07143084 ENROLLING_BY_INVITATION
Characteristics and Outcomes of Patients With COVID-19 Admitted to the ICU
NCT04378582 COMPLETED
Characteristics of Critically Ill COVID 19 Patients
NCT04465058 UNKNOWN
Scoring Systems covid19
NCT05308524 UNKNOWN
Risk Factors for Mortality for COVID-19 Admitted to an Intensive Care Unit
NCT04805645 TERMINATED
Phosphate Urine Excretion in Critically Ill Patients
NCT06779331 ACTIVE_NOT_RECRUITING
High-Dose Vitamin C Treatment in Critically Ill COVID-19 Patients
NCT04710329 COMPLETED
Assessment of Clinical Effects of Coenzyme Q10 Levels in COVID-19 Patients in Intensive Care Unit
NCT05058716 UNKNOWN
COVID-19 Patients Admitted to the ICU
NCT04816786 UNKNOWN
PREdiction of DIagnosed Covid-19 infecTion in IUC Patients
NCT04327180 COMPLETED
Arterial and End-Tidal CO2 Gradient as a Mortality Predictor in Critical Care Patients
NCT05341258 COMPLETED NA
Sarcopenia and Related Factors in Coronavirus Disease 2019 (COVID-19) Following Intensive Care
NCT05474157 TERMINATED
Clinical Characteristics, Outcomes and Risk Factors for Mortality in Pregnant/Puerperal Women With COVID-19 Admitted to ICU in Turkey: a Multicenter, Retrospective Study From a Middle-income Country.
NCT05930340 COMPLETED
Reliability of Respiratory Variability of Maximal Aortic Blood Flow Velocity Obtained by Ultrasonography-doppler in Patients Followed Up with a Diagnosis of Shock in Intensive Care Unit for Evaluating Fluid Responsiveness in Patients
NCT06845280 NOT_YET_RECRUITING
Clinical Characteristics and Outcomes of 187 Critically Ill Patients With Coronavirus Disease 2019 (COVID-19)
NCT04454372 COMPLETED
Sepsis in ICU:Causes and Outcomes of Sepsis in Diabetics Versus Non Diabetics in Assiut University Hospital
NCT04015752 UNKNOWN
Investigation of Validity and Reliability of Post-COVID-19 Functional Status Scale
NCT04584450 COMPLETED
One-year Outcomes in Survivors of the Severe COVID-19 Pneumonia (CO-Qo-ICU)
NCT04401111 RECRUITING
Relationship Between Delirium Severity by CAM-ICU 7 and 4C Mortality Score of the COVID-19 Patients in ICU
NCT04812041 UNKNOWN
Lung Ultrasound in COVID-19 Patients
NCT04487769 COMPLETED
Early Versus Delayed Enteral Nutrition in Critically Ill Adults With COVID-19
NCT06134674 COMPLETED
Predictive Value of the mNutric Score and Survival Analysis in Critically Ill Patients Hospitalised in the Intensive Care Unit
NCT06912204 COMPLETED
Is a Positive NECPAL in ICU Patients Associated With Higher Mortality
NCT07007156 RECRUITING